(1)
Bonadio, R. R. da C. C.; Tavares, M.; Rosa, D. D.; Brito, M. L. de; Gagliato, D. de M.; Suzuki, D. A.; Testa, L.; Sousa, R. B. Dose-Dense Versus 3-Weekly Ac During Neoadjuvant Chemoimmunotherapy for Early-Stage Triple-Negative Breast Cancer: GBECAM 0123 – the Neo-Real Study. MAST 2026, 34.